Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today.
Reported sales decreased 4.4% year-over-year to $23.7 billion.
Net earnings were down 25% to $3.5 billion, or $1.33 per share, compared to the prior-year period. Adjusted EPS increased 10.3% to $2.35 from last year.
Adjusted EPS beat estimates while sales fell short of expectations.
For the full year of 2023, the company expects reported sales to range between $96.9-97.9 billion and adjusted EPS to range between $10.45-10.65.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,